Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma

HPB

Volumn 11, Issue 4, 2009, Pages 351-357

  Delis, Spiros G ^a,b   Bakoyiannis, Andreas ^b   Biliatis, Ioannis ^b   Athanassiou, Konstantinos ^b   Tassopoulos, Nikos ^c   Dervenis, Christos ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b AGIA OLGA HOSPITAL   (Greece)

^c Western Attica General Hospital   (Greece)

Author keywords

Cirrhosis; Hepatectomy; Hepatocellular carcinoma; Liver resection outcome; MELD score

Indexed keywords

BILIRUBIN; DIURETIC AGENT;

AGED; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; INSTRUMENT VALIDATION; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MEDICAL RECORD REVIEW; MINOR SURGERY; MODEL FOR END STAGE LIVER DISEASE SCORE; MORBIDITY; OUTCOME ASSESSMENT; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURGICAL MORTALITY; SURVIVAL TIME; TUMOR VOLUME;

EID: 70349174887     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00067.x     Document Type: Article

References (32)

1. El-serag HB. (2001) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 5:87-107.
2. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM. (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234:63-70.
3. Belghiti J, Regimbeau JM, Durand F, Kianmanesh AR, Dondero F, Terris B. (2002) Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 49:41-46.
4. Bilimoria MM, Lauwers GY, Doherty DA, Nagorney DM, Belghiti J, Do KA. (2001) Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 136:528-535.
5. Franco D, Capussoti L, Smadja C, Bouzari H, Meakins J, Kemeny F. (1990) Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 98:733-738.
6. Paquet KJ, Gad HA, Lazar A, Koussouris P, Mercado MA, Heine WD. (1998) Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma. Eur J Surg 164:513-519.
7. Wayne JD, Lauwers GY, Ikai I, Doherty DA, Belghiti J, Yamaoka G. (2002) Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 235:722-731.
8. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. (1995) Criteria for safe hepatic resection. Am J Surg 169:589-594.
9. Lau H, Man K, Fan ST, Yu WC, Lo CM, Woug J. (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84:1255-1259.
10. Ercolani G, Grazi GL, Calliva R, Pierangeli F, Cescon M, Cavallari A. (2000) The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery. Surgery 127:464-471.
11. Radaelli CA, Dufour JF, Wagner M, Schilling M, Hüsler J, Krähenbühl L. (2002) Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 235:77-85.
12. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. (2000) A model to predict poor survival in patients undergoing transjujalar intrahepatic portosystemic shunts. Hepatology 31:864-871.
13. Freeman RB, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E. (2002) The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 8:851-858.
14. Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. (2005) Model for end-stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 242:244-251.
15. Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM. (2005) The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg 140:650-654.
16. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:646-649.
17. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699.
18. Belghiti J, Clavien P-A, Gadzijev E, Garden JO, Lau WY, Makuuchi M. (2000) The Brisbane 2000 terminology of liver anatomy and resections terminology committee of the international hepato-pancreato-biliary association: Chairman, SM Strasberg (USA). HPB (Oxford) 2:333-339.
19. Edmondson HA, Steiner PE. (1954) Primary carcinoma of the liver. A study of 100 cases among 48 900 necropsies. Cancer 7:462-503.
20. American Joint Committee on Cancer. (2002) AJCC Cancer Staging Manual, 6th edn. New York: Springer, pp. 145-153.
21. Teh SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M. (2005) Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model for end-stage liver disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 9:1207-1215.
22. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G. (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966-971.
23. Grazi GL, Ercolani G, Pierangeli F, Del Gaudio M, Cescon M, Cavallari A. (2000) Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 234:71-78.
24. Poon RT, Fan ST. (2004) Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 10 (Suppl.): S39-S45.
25. Song TJ, Ip EW, Fong Y. (2004) Hepatocellular carcinoma: current surgical management. Gastroenterology 127 (Suppl.):S248-S260.
26. Ikai I, Arii S, Kojiro M, Ikida T et al. (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 101:796-802.
27. Belghiti J, Cortes A, Abdalla EK, Regimbeau JM et al. (2003) Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 238:925-928.
28. Merion RM, Schaubel DE, Dykstra DM, Freeman RB et al. (2005) The survival benefit of liver transplantation. Am J Transplant 5:307-312.
29. Imai H, Nakano Y, Kiyosawa K, Tan EM. (1993) Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer 71:26-35.
30. Ledesma F, Echevarria S, Casafont F, Lozano JL et al. (1990) Natural killer cell activity in alcoholic cirrhosis: influence of nutrition. Eur J Clin Nutr 44:733-740.
31. Pang RW, Joh JW, Johnson PJ, Monden M et al. (2008) Biology of hepatocellular carcinoma. Ann Surg Oncol 15:962-971.
32. Schroeder RA, Marroquin CE, Bute BP, Khuri S et al. (2006) Predictive indices of morbidity and mortality after liver resection. Ann Surg 243:373-379.